Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects
- PMID: 3014663
- DOI: 10.1126/science.3014663
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects
Abstract
A variant of human T-lymphotropic virus type III (HTLV-III) is described that replicates but does not kill normal human T cells in vitro. This variant, designated X10-1, was derived from the genome of a cytopathic HTLV-III clone (pHXB2D) by excision of a 200-base pair segment in the 3' region of the virus, spanning the env and 3'-orf genes. Comparable variants with 55 to 109 base pairs deleted exclusively in 3'-orf produced, in contrast, virus that was extremely cytopathic. On the basis of these findings it is concluded that the 3'-orf gene is not required for cytopathogenicity or replication of HTLV-III. In addition, the results suggest that virus replication and cytotoxicity are not intrinsically coupled. Furthermore, since clone X10-1 retains the ability to trans-activate genes linked to the viral long terminal repeats, trans-activation per se is not responsible for T-cell killing by HTLV-III. These results also raise the possibility that the carboxyl terminus of the envelope gene of HTLV-III has a direct role in T-cell killing by this virus.
Similar articles
-
Molecular biology of human T-lymphotropic retroviruses.Cancer Res. 1985 Sep;45(9 Suppl):4539s-4544s. Cancer Res. 1985. PMID: 2990683 Review.
-
A molecular clone of HTLV-III with biological activity.Nature. 1985 Jul 18-24;316(6025):262-5. doi: 10.1038/316262a0. Nature. 1985. PMID: 2410792
-
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.Science. 1986 Mar 28;231(4745):1549-53. doi: 10.1126/science.3006244. Science. 1986. PMID: 3006244
-
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.Science. 1984 Aug 31;225(4665):927-30. doi: 10.1126/science.6089333. Science. 1984. PMID: 6089333
-
Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.Princess Takamatsu Symp. 1984;15:277-88. Princess Takamatsu Symp. 1984. PMID: 6085846 Review.
Cited by
-
Immunological study of the nef protein from HIV-1 by polyclonal and monoclonal antibodies.Arch Virol. 1991;118(1-2):29-41. doi: 10.1007/BF01311301. Arch Virol. 1991. PMID: 2048974
-
The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.J Virol. 1989 Mar;63(3):1265-74. doi: 10.1128/JVI.63.3.1265-1274.1989. J Virol. 1989. PMID: 2783738 Free PMC article.
-
An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.Proc Natl Acad Sci U S A. 1988 Mar;85(5):1652-6. doi: 10.1073/pnas.85.5.1652. Proc Natl Acad Sci U S A. 1988. PMID: 2830625 Free PMC article.
-
Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.J Virol. 1992 Nov;66(11):6616-25. doi: 10.1128/JVI.66.11.6616-6625.1992. J Virol. 1992. PMID: 1357190 Free PMC article.
-
3'-orf and sor genes of human immunodeficiency virus: in vitro transcription-translation and immunoreactive domains.Proc Natl Acad Sci U S A. 1987 Aug;84(15):5429-33. doi: 10.1073/pnas.84.15.5429. Proc Natl Acad Sci U S A. 1987. PMID: 3496604 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
